Skip to main content

Animations

MJFF Publications

8641 - 8650 of 9131 Results
Title
Year
  • Year
  • 2024
  • 2025
  • 2025
  • 2024
  • 2025
  • 2020
  • 2023
  • 2025
  • 2021
  • 2020
  • Summary Details
    OPEN
    Title: A comprehensive head-to-head comparison of key plasma phosphorylated tau 217 biomarker tests
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1093/brain/awae346
    Citation Count: 102
  • Summary Details
    OPEN
    Title: Peripheral immune cell response to stimulation stratifies Parkinson’s disease progression from prodromal to clinical stages
    Journal Name: Communications Biology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s42003-025-08088-7
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Quantitative 3D histochemistry reveals region-specific amyloid-β reduction by the antidiabetic drug netoglitazone
    Journal Name: PLOS One
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc0
    DOI - Digital Object Identifier: 10.1371/journal.pone.0309489
    Citation Count: 0
  • Summary Details
    OPEN
    Title: A proteome-wide quantitative platform for nanoscale spatially resolved extraction of membrane proteins into native nanodiscs
    Journal Name: Nature Methods
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41592-024-02517-x
    Citation Count: 12
  • Summary Details
    OPEN
    Title: Parkinson’s disease is characterized by vitamin B6-dependent inflammatory kynurenine pathway dysfunction
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-025-00964-7
    Citation Count: 16
  • Summary Details
    OPEN
    Title: The Effect of the COVID-19 Pandemic on People with Parkinson’s Disease
    Journal Name: Journal of Parkinson's Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3233/jpd-202249
    Citation Count: 178
  • Summary Details
    OPEN
    Title: Differential LRRK2 Signalling and Gene Expression in WT-LRRK2 and G2019S-LRRK2 Mouse Microglia Treated with Zymosan and MLi2
    Journal Name: Cells
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/cells13010053
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Prioritizing Parkinson’s disease risk genes in genome-wide association loci
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-025-00933-0
    Citation Count: 10
  • Summary Details
    OPEN
    Title: Deciphering the LRRK code: LRRK1 and LRRK2 phosphorylate distinct Rab proteins and are regulated by diverse mechanisms
    Journal Name: Biochemical Journal
    Publisher: Portland Press Ltd.
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1042/bcj20200937
    Citation Count: 54
  • Summary Details
    OPEN
    Title: Fox Insight collects online, longitudinal patient-reported outcomes and genetic data on Parkinson’s disease
    Journal Name: Scientific Data
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41597-020-0401-2
    Citation Count: 112
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.